keyword
https://read.qxmd.com/read/38004523/a-single-run-hplc-ms-multiplex-assay-for-therapeutic-drug-monitoring-of-relevant-first-and-second-line-antibiotics-in-the-treatment-of-drug-resistant-tuberculosis
#21
JOURNAL ARTICLE
Niklas Köhler, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen, Harald Hoffmann, Dražen Strelec, Dagmar Schaub, Charles A Peloquin, Stefan Schmiedel, Laurent A Decosterd, Eva Choong, Sebastian G Wicha, Rob E Aarnoutse, Christoph Lange, Patricia M Sánchez Carballo
The treatment of drug-resistant Mycobacterium tuberculosis relies on complex antibiotic therapy. Inadequate antibiotic exposure can lead to treatment failure, acquired drug resistance, and an increased risk of adverse events. Therapeutic drug monitoring (TDM) can be used to optimize the antibiotic exposure. Therefore, we aimed to develop a single-run multiplex assay using high-performance liquid chromatography-mass spectrometry (HPLC-MS) for TDM of patients with multidrug-resistant, pre-extensively drug-resistant and extensively drug-resistant tuberculosis...
October 27, 2023: Pharmaceutics
https://read.qxmd.com/read/38004437/pharmacotherapies-targeting-gaba-glutamate-neurotransmission-for-treatment-resistant-depression
#22
REVIEW
Courtney M Vecera, Alan C Courtes, Gregory Jones, Jair C Soares, Rodrigo Machado-Vieira
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with or without electroconvulsive therapy (ECT). That is why TRD is such a growing concern among clinicians and researchers, and it explains the necessity for investigating novel therapeutic targets beyond conventional monoamine pathways. An imbalance between two primary central nervous system (CNS) neurotransmitters, L -glutamate and γ-aminobutyric acid (GABA), has emerged as having a key role in the pathophysiology of TRD...
November 7, 2023: Pharmaceuticals
https://read.qxmd.com/read/37979218/what-good-are-positive-emotions-for-treatment-a-replication-test-of-whether-trait-positive-emotionality-predicts-response-to-exposure-therapy-for-social-anxiety-disorder
#23
JOURNAL ARTICLE
Charles T Taylor, David Rosenfield, Sheila M Dowd, Christina D Dutcher, Stefan G Hofmann, Michael W Otto, Mark H Pollack, Jasper A J Smits
BACKGROUND: Positive valence emotions serve functions that may facilitate response to exposure therapy - they encourage approach behavior, diminish perceived threat reactivity, and enhance assimilation of new information in memory. Few studies have examined whether positive emotions predict exposure therapy success and extant findings are mixed. METHODS: We conducted a secondary analysis of an exposure therapy trial for social anxiety disorder to test the hypothesis that patients endorsing higher trait positive emotions at baseline would display the greatest treatment response...
November 11, 2023: Behaviour Research and Therapy
https://read.qxmd.com/read/37971239/optimizing-dosing-of-the-cycloserine-pro-drug-terizidone-in-children-with-rifampicin-resistant-tuberculosis
#24
JOURNAL ARTICLE
Louvina E van der Laan, Anthony J Garcia-Prats, Helen McIlleron, Mahmoud T Abdelwahab, Jana L Winckler, Heather R Draper, Lubbe Wiesner, H Simon Schaaf, Anneke C Hesseling, Paolo Denti
There are no pharmacokinetic data in children on terizidone, a pro-drug of cycloserine and a World Health Organization (WHO)-recommended group B drug for rifampicin-resistant tuberculosis (RR-TB) treatment. We collected pharmacokinetic data in children <15 years routinely receiving 15-20 mg/kg of daily terizidone for RR-TB treatment. We developed a population pharmacokinetic model of cycloserine assuming a 2-to-1 molecular ratio between terizidone and cycloserine. We included 107 children with median (interquartile range) age and weight of 3...
November 16, 2023: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/37948922/structure-guided-design-and-synthesis-of-atp-competitive-n-acyl-substituted-sulfamide-d-alanine-d-alanine-ligase-inhibitors
#25
JOURNAL ARTICLE
Rouven Becker, Jordan L Pederick, Edward G Dawes, John B Bruning, Andrew D Abell
d-Alanine-d-alanine ligase (Ddl) catalyses the ATP-dependent formation of d-Ala-d-Ala, a critical component in bacterial cell wall biosynthesis and is a validated target for new antimicrobial agents. Here, we describe the structure-guided design, synthesis, and evaluation of ATP-competitive N-acyl-substituted sulfamides 27-36, 42, 46, 47 as inhibitors of Staphylococcus aureus Ddl (SaDdl). A crystal structure of SaDdl complexed with ATP and d-Ala-d-Ala (PDB: 7U9K) identified ATP-mimetic 8 as an initial scaffold for further inhibitor design...
October 26, 2023: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/37945694/synergistic-psychedelic-nmdar-modulator-treatment-for-neuropsychiatric-disorders
#26
REVIEW
Uriel Heresco-Levy, Bernard Lerer
Modern research data suggest a therapeutic role for serotonergic psychedelics in depression and other neuropsychiatric disorders, although psychotomimetic effects may limit their widespread utilization. Serotonergic psychedelics enhance neuroplasticity via serotonin 2 A receptors (5HT2AR) activation and complex serotonergic-glutamatergic interactions involving the ionotropic glutamate receptors, tropomyosin receptor kinase B (TrkB) and the mammalian target of rapamycin (mTOR). N-methyl-d-aspartate receptors (NMDAR) channel antagonists, i...
November 9, 2023: Molecular Psychiatry
https://read.qxmd.com/read/37882578/biosensor-guided-detection-of-outer-membrane-specific-antimicrobial-activity-against-pseudomonas-aeruginosa-from-fungal-cultures-and-medicinal-plant-extracts
#27
JOURNAL ARTICLE
Steve Shideler, Tyson Bookout, Azka Qasim, Lauren Bowron, Qiaolian Wu, Kangmin Duan, Roland Treu, Shauna Reckseidler-Zenteno, Shawn Lewenza
Pseudomonas aeruginosa responds to sub-lethal antimicrobial exposure by inducing the expression of lipopolysaccharide (LPS) surface modifications that mask antibiotic binding sites and contribute to repair and resistance of the outer membrane (OM). We exploit these membrane damage-responsive operons in a biosensor approach used to discover new antimicrobials that specifically target the OM. Chromosomal transcriptional luxCDABE reporters from the pmr (polymyxin resistance; aminoarabinose LPS modification) and speD2E2 (spermidine synthesis) operons are induced by validated outer membrane-acting agents including cationic antimicrobial peptides, cation chelators, ascorbic acid, detergents, and cell wall synthesis inhibitors cycloserine and bacitracin...
October 26, 2023: Microbiology Spectrum
https://read.qxmd.com/read/37878718/olfactory-threat-extinction-in-the-piriform-cortex-an-age-dependent-employment-of-nmda-receptor-dependent-long-term-depression
#28
JOURNAL ARTICLE
Tayebeh Sepahvand, Negar Nazari, Tian Qin, Vishaal Rajani, Qi Yuan
Extinction of threat memory is a measure of behavioral flexibility. In the absence of additional reinforcement, the extinction of learned behaviors allows animals and humans to adapt to their changing environment. Extinction mechanisms and their therapeutic implications for maladaptive learning have been extensively studied. However, how aging affects extinction learning is much less understood. Using a rat model of olfactory threat extinction, we show that the extinction of olfactory threat memory is impaired in aged Sprague-Darley rats...
October 31, 2023: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/37689346/malate-quinone-oxidoreductase-knockout-makes-mycobacterium-tuberculosis-susceptible-to-stress-and-affects-its-in-vivo-survival
#29
JOURNAL ARTICLE
Ram Kumar, Princi Sharma, Anu Chauhan, Nirbhay Singh, V M Prajapati, Sudheer Kumar Singh
Mycobacterium tuberculosis H37Ra (Mtb-Ra) ORF MRA_2875, annotated as malate:quinone oxidoreductase (mqo), is thought to have a role in TCA cycle in converting malate to oxaloacetate. To study its physiological relevance, we developed mqo knockout (KO) in Mtb-Ra. A KO complemented (KOC) strain was also developed by complementing the KO with mqo over-expressing construct. Under normal in vitro conditions, KO does not show any growth defect but showed reduced CFU burden in macrophages and in mice lungs. In vitro studies with KO showed reduced fitness under oxidative and low pH stress, and also increased susceptibility to levofloxacin and D-cycloserine...
September 7, 2023: Microbes and Infection
https://read.qxmd.com/read/37587754/clinical-characteristics-in-26-children-with-congenital-tuberculosis-in-central-southern-china-a-retrospective-study
#30
JOURNAL ARTICLE
Feng Zhang, Xiao-Fo Zhang, Hai-Yi Zhou
BACKGROUND: Congenital tuberculosis (CTB) is relatively rare and most patients are described in case reports. AIM: To investigate the clinical characteristics of CTB in 26 children. METHODS: A retrospective analysis of 26 children with CTB from January 2013 to December 2021 in Changsha Central Hospital in Central Southern China was undertaken. RESULTS: The median age at onset was 25 days (17-33) and within 4 weeks of age in approximately 73% of cases...
2022: Paediatrics and International Child Health
https://read.qxmd.com/read/37584834/enhancing-fear-extinction-pharmacological-approaches
#31
JOURNAL ARTICLE
Olga Y Ponomareva, Robert J Fenster, Kerry J Ressler
Extinction is the process by which the memory of a learned conditioned association decreases over time and with introduction of new associations. It is a vital part of fear learning, and it is critical to recovery in multiple fear-related disorders, including Specific and Social Phobias, Panic Disorder, Obsessive Compulsive Disorder (OCD), and Posttraumatic Stress Disorder (PTSD). The process of extinction is also the underlying mechanism for recovery in gold-standard therapies for PTSD, including prolonged exposure, cognitive processing therapy, eye movement desensitization and procession, as well as other empirically-based paradigms...
August 17, 2023: Current Topics in Behavioral Neurosciences
https://read.qxmd.com/read/37581574/comparative-functional-and-structural-analysis-of-pseudomonas-aeruginosa-%C3%A1-alanine-%C3%A1-alanine-ligase-isoforms-as-prospective-antibiotic-targets
#32
JOURNAL ARTICLE
Jordan L Pederick, Jessica C Woolman, John B Bruning
Pseudomonas aeruginosa is a major human pathogen in the healthcare setting. The emergence of multi-drug-resistant and extensive drug-resistant P. aeruginosa is of great concern, and clearly indicates that new alternatives to current first-line antibiotics are required in the future. Inhibition of ᴅ-alanine-ᴅ-alanine production presents as a promising avenue as it is a key component in the essential process of cell wall biosynthesis. In P. aeruginosa, ᴅ-alanine-ᴅ-alanine production is facilitated by two isoforms, ᴅ-alanine-ᴅ-alanine ligase A (PaDdlA) and ᴅ-alanine-ᴅ-alanine ligase B (PaDdlA), but neither enzyme has been individually characterised to date...
August 15, 2023: FEBS Journal
https://read.qxmd.com/read/37573534/nrx-101-d-cycloserine-plus-lurasidone-vs-lurasidone-for-the-maintenance-of-initial-stabilization-after-ketamine-in-patients-with-severe-bipolar-depression-with-acute-suicidal-ideation-and-behavior-a-randomized-prospective-phase-2-trial
#33
JOURNAL ARTICLE
Andrew Nierenberg, Philip Lavin, Daniel C Javitt, Richard Shelton, Michael T Sapko, Sanjay Mathew, Robert E Besthof, Jonathan C Javitt
BACKGROUND: We tested the hypothesis that, after initial improvement with intravenous ketamine in patients with bipolar disorder (BD) with severe depression and acute suicidal thinking or behavior, a fixed-dose combination of oral D-cycloserine (DCS) and lurasidone (NRX-101) can maintain improvement more effectively than lurasidone alone. METHODS: This was a multi-center, double-blind, twostage, parallel randomized trial. Adult BD patients with depression and suicidal ideation or behavior were infused with ketamine or saline (Stage 1); those who improved were randomized to a fixed-dose combination of DCS and lurasidone vs...
August 13, 2023: International Journal of Bipolar Disorders
https://read.qxmd.com/read/37567554/selecting-an-appropriate-all-oral-short-course-regimen-for-patients-with-multidrug-resistant-or-pre-extensive-drug-resistant-tuberculosis-in-china-a-multicenter-prospective-cohort-study
#34
JOURNAL ARTICLE
Liang Fu, Xilin Zhang, Juan Xiong, Feng Sun, Taoping Weng, Yang Li, Peize Zhang, Hui Li, Qianting Yang, Yi Cai, Hancheng Liang, Qiuqi Chen, Zhaoqing Wang, Lei Liu, Xinchun Chen, Wenhong Zhang, Guofang Deng
BACKGROUND: Long, ineffective, and toxic regimens hinder the treatment of patients with multidrug-resistant tuberculosis (MDR-TB) and pre-extensive drug-resistant tuberculosis (pre-XDR-TB). METHODS: We conducted a multicenter cohort study to prospectively evaluate the safety and efficacy of three 9-month, all-oral, 5-drug regimens. Regimen A (bedaquiline [Bdq]+linezolid [Lzd]+moxifloxacin [Mfx]+cycloserine [Cs]+pyrazinamide [Pza]) and Regimen B (Lzd+Mfx+Cs+clofazimine [Cfz]+Pza) were used to treat MDR-TB patients (Groups A and B, respectively, assigned according to the patients' treatment preference), while Regimen C (Bdq+Lzd+Cs+Cfz+Pza) was used to treat pre-XDR-TB patients (Group C)...
August 9, 2023: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/37525044/cognitive-rehabilitation-for-patients-with-schizophrenia-a-narrative-review-of-moderating-factors-strategies-and-outcomes
#35
JOURNAL ARTICLE
Maria Skokou, Lambros Messinis, Grigorios Nasios, Philippos Gourzis, Euthymios Dardiotis
OBJECTIVE: Antipsychotic drugs constitute the basis of schizophrenia therapy; however, available pharmaceutical agents lack efficacy for treating the cognitive deficits caused by the illness. The aim of the present work is to present current data regarding cognitive rehabilitation of schizophrenia, providing information and guidance to health professionals. METHOD: A literature search was conducted in the PubMed and Google Scholar Databases from inception up to 1/9/2022...
2023: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/37468047/preventing-development-of-post-stroke-hyperexcitability-by-optogenetic-or-pharmacological-stimulation-of-cortical-excitatory-activity
#36
JOURNAL ARTICLE
Yadav Adhikari, Cun-Gen Ma, Zhi Chai, Xiaoming Jin
Stroke is the most common cause of acquired epilepsy, but treatment for preventing the development of post-stroke epilepsy is still unavailable. Since stroke results in neuronal damage and death as well as initial loss of activity in the affected brain region, homeostatic plasticity may be trigged and contribute to an increase in network hyperexcitability that underlies epileptogenesis. Correspondingly, enhancing brain activity may inhibit hyperexcitability from enhanced homeostatic plasticity and prevent post-stroke epileptogenesis...
August 2023: Neurobiology of Disease
https://read.qxmd.com/read/37399757/using-pre-treatment-de-novo-threat-conditioning-outcomes-to-predict-treatment-response-to-dcs-augmentation-of-exposure-based-cbt
#37
JOURNAL ARTICLE
Rebecca E Lubin, Hayley E Fitzgerald, David Rosenfield, Joseph K Carpenter, Santiago Papini, Christina D Dutcher, Sheila M Dowd, Stefan G Hofmann, Mark H Pollack, Jasper A J Smits, Michael W Otto
BACKGROUND: Over a decade and a half of research has resulted in inconsistent evidence for the efficacy of d-cycloserine (DCS), a partial glutamatergic N-methyl-D-aspartate agonist, for augmenting exposure-based cognitive behavioral therapy (CBT) for anxiety- and fear-based disorders. These variable findings have motivated the search for moderators of DCS augmentation efficacy. METHODS: In this secondary analysis of a previous randomized clinical trial, we evaluated the value of de novo threat conditioning outcomes-degree of threat acquisition, extinction, and extinction retention-for predicting treatment response to exposure-based CBT for social anxiety disorder, applied with and without DCS augmentation in a sample of 59 outpatients...
June 19, 2023: Journal of Psychiatric Research
https://read.qxmd.com/read/37363078/structure-of-the-d-cycloserine-resistant-variant-d322n-of-alanine-racemase-from-mycobacterium-tuberculosis
#38
JOURNAL ARTICLE
Cesira de Chiara, Gareth A Prosser, Roksana Ogrodowicz, Luiz P S de Carvalho
Alanine racemase (Alr) is a pyridoxal 5'-phosphate-dependent enzyme that catalyzes the racemization of l-alanine to d-alanine. Alr is one of the two targets of the broad-spectrum antibiotic d-cycloserine (DCS), a structural analogue of d-alanine. Despite being an essential component of regimens used to treat multi- and extensively drug-resistant tuberculosis for almost seven decades, resistance to DCS has not been observed in patients. We previously demonstrated that DCS evades resistance due to an ultralow rate of emergence of mutations...
June 21, 2023: ACS Bio Med Chem Au
https://read.qxmd.com/read/37335203/clinical-recommendations-for-augmentation-agents-in-obsessive-compulsive-disorder-partially-responsive-to-serotonin-reuptake-inhibitors
#39
REVIEW
Mohan Gautam
BACKGROUND: Obsessive-compulsive disorder (OCD) affects 2% to 3% of adults worldwide. Although serotonin reuptake inhibitors (SRIs) reliably demonstrate efficacy for this condition, 40% to 60% of patients only achieve partial recovery. The purpose of this systematic review was to assess the efficacy of other agents that may be used as augmentation agents for patients who are partial responders to SRI monotherapy. METHODS: Using PRISMA-P guidelines, PubMed and Embase were searched using the randomized controlled trial (RCT) filter and the key word "obsessive-compulsive disorder...
July 2023: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/37331714/mechanism-of-d-cycloserine-inhibition-of-d-amino-acid-transaminase-from-haliscomenobacter-hydrossis
#40
JOURNAL ARTICLE
Alina K Bakunova, Ilya O Matyuta, Alena Yu Nikolaeva, Konstantin M Boyko, Vladimir O Popov, Ekaterina Yu Bezsudnova
D-cycloserine inhibits pyridoxal-5'-phosphate (PLP)-dependent enzymes. Inhibition effect depend on organization of the active site and mechanism of the catalyzed reaction. D-cycloserine interacts with the PLP form of the enzyme similarly to the substrate (amino acid), and this interaction is predominantly reversible. Several products of the interaction of PLP with D-cycloserine are known. For some enzymes formation of a stable aromatic product - hydroxyisoxazole-pyridoxamine-5'-phosphate at certain pH - leads to irreversible inhibition...
May 2023: Biochemistry. Biokhimii︠a︡
keyword
keyword
107137
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.